Issuer Delisting; Notice of Application of Eli Lilly and Company To Withdraw Its Common Stock, No Par Value, From Listing and Registration on the Pacific Exchange, Inc., 7082 [E6-1844]
Download as PDF
7082
Federal Register / Vol. 71, No. 28 / Friday, February 10, 2006 / Notices
SECURITIES AND EXCHANGE
COMMISSION
The Issuer stated in its application
that it has complied with applicable
rules of PCX by providing PCX with the
required documents governing the
withdrawal of securities from listing
and registration on PCX. The Issuer’s
application relates solely to the
withdrawal of the Security from listing
on PCX, and shall not affect its
continued listing on NYSE or its
obligation to be registered under section
12(b) of the Act.3
Any interested person may, on or
before February 28, 2006, comment on
the facts bearing upon whether the
application has been made in
accordance with the rules of PCX, and
what terms, if any, should be imposed
by the Commission for the protection of
investors. All comment letters may be
submitted by either of the following
methods:
[File No. 1–06351]
Electronic Comments
Issuer Delisting; Notice of Application
of Eli Lilly and Company To Withdraw
Its Common Stock, No Par Value, From
Listing and Registration on the Pacific
Exchange, Inc.
• Use the Commission’s Internet
comment form (https://www.sec.gov/
rules/delist.shtml); or
• Send an e-mail to rulecomments@sec.gov. Please include the
File Number 1–06351 or;
All comments received will be posted
without change; we do not edit personal
identifying information from
submissions. You should submit only
information that you wish to make
available publicly.
The Commission, based on the
information submitted to it, will issue
an order granting the application after
the date mentioned above, unless the
Commission determines to order a
hearing on the matter.
For the Commission, by the Division of
Market Regulation, pursuant to delegated
authority.5
Nancy M. Morris,
Secretary.
[FR Doc. E6–1845 Filed 2–9–06; 8:45 am]
BILLING CODE 8010–01–P
rmajette on PROD1PC67 with NOTICES1
February 2, 2006.
On December 23, 2005, Eli Lilly and
Company, an Indiana corporation
(‘‘Issuer’’), filed an application with the
Securities and Exchange Commission
(‘‘Commission’’), pursuant to section
12(d) of the Securities Exchange Act of
1934 (‘‘Act’’) 1 and Rule 12d2–2(d)
thereunder,2 to withdraw its common
stock, no par value (‘‘Security’’), from
listing and registration on the Pacific
Exchange, Inc. (‘‘PCX’’).
On June 24, 2005, the Board of
Directors (‘‘Board’’) of the Issuer
adopted resolutions to withdraw the
Security from listing and registration on
PCX. The Issuer stated that it
determined to withdraw the Security
from PCX for the followings reasons: (i)
The Issuer maintains its primary listing
on the New York Stock Exchange, Inc.
(‘‘NYSE’’) as well as its secondary
listings on the London Stock Exchange
and the SWX Swiss Stock Exchange; (ii)
the Security is widely traded on several
electronic exchanges; (iii) in light of the
strong liquidity and visibility of the
trading market for the Security on NYSE
and other exchanges, the additional
expenses and administrative burden of
maintaining a secondary listing on PCX
outweigh the benefits of maintaining the
listing on PCX.
CFR 200.30–3(a)(1).
U.S.C. 78l(d).
2 17 CFR 240.12d2–2(d).
Paper Comments
• Send paper comments in triplicate
to Nancy M. Morris, Secretary,
Securities and Exchange Commission,
100 F Street, NE., Washington, DC
20549–1090.
All submissions should refer to File
Number 1–06351. This file number
should be included on the subject line
if e-mail is used. To help us process and
review your comments more efficiently,
please use only one method. The
Commission will post all comments on
the Commission’s Internet Web site
(https://www.sec.gov/rules/delist.shtml).
Comments are also available for public
inspection and copying in the
Commission’s Public Reference Room.
All comments received will be posted
without change; we do not edit personal
identifying information from
submissions. You should submit only
information that you wish to make
available publicly.
The Commission, based on the
information submitted to it, will issue
an order granting the application after
the date mentioned above, unless the
Commission determines to order a
hearing on the matter.
5 17
1 15
VerDate Aug<31>2005
15:10 Feb 09, 2006
3 15
Jkt 208001
PO 00000
U.S.C. 78l(b).
Frm 00081
Fmt 4703
Sfmt 4703
For the Commission, by the Division of
Market Regulation, pursuant to delegated
authority.4
Nancy M. Morris,
Secretary.
[FR Doc. E6–1844 Filed 2–9–06; 8:45 am]
BILLING CODE 8010–01–P
SECURITIES AND EXCHANGE
COMMISSION
[Release No. 34–53227; File No. PCAOB–
2005–01]
Public Company Accounting Oversight
Board; Order Approving Proposed
Auditing Standard No. 4, Reporting on
Whether a Previously Reported
Material Weakness Continues to Exist
February 6, 2006.
I. Introduction
On July 28, 2005, the Public Company
Accounting Oversight Board (the
‘‘Board’’ or the ‘‘PCAOB’’) filed with the
Securities and Exchange Commission
(‘‘Commission’’) proposed Auditing
Standard No. 4, Reporting on Whether a
Previously Reported Material Weakness
Continues to Exist, pursuant to the
Sarbanes-Oxley Act of 2002 (the
‘‘Act’’) 1 and Section 19(b) of the
Securities Exchange Act of 1934 (the
‘‘Exchange Act’’).2 Auditing Standard
No. 4 establishes requirements that
apply when an auditor is engaged to
report on whether a previously reported
material weakness in internal control
over financial reporting continues to
exist.3 Also, in connection with
proposed Auditing Standard No. 4, the
Board adopted a proposed conforming
amendment to AT sec. 101, which
encompasses agreed-upon procedures
engagements in which an auditor
reports findings based on specific
procedures performed on a subject
matter. AT sec. 101, Attest
Engagements, is one of the interim
attestation standards adopted by the
PCAOB in April 2003.4 Notice of
proposed Auditing Standard No. 4 and
proposed amendment to AT sec. 101
(collectively referred to as the
‘‘Proposed Standard’’) was published in
4 17
CFR 200.30–3(a)(1).
U.S.C. 7202 et seq.
2 15 U.S.C. 78s(b).
3 A previously reported material weakness, in the
context of the proposed auditing standard, means
a material weakness that was described previously
in an auditor’s report issued pursuant to PCAOB
Auditing Standard No. 2, An Audit of Internal
Control Over Financial Reporting Performed in
Conjunction with an Audit of Financial Statements.
4 The Commission approved the PCAOB’s
adoption of the interim standards in Release No.
34–47745, Order Regarding Section 103(a)(3)(B) of
the Sarbanes-Oxley Act of 2002 (April 25, 2003).
1 15
E:\FR\FM\10FEN1.SGM
10FEN1
Agencies
[Federal Register Volume 71, Number 28 (Friday, February 10, 2006)]
[Notices]
[Page 7082]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-1844]
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
[File No. 1-06351]
Issuer Delisting; Notice of Application of Eli Lilly and Company
To Withdraw Its Common Stock, No Par Value, From Listing and
Registration on the Pacific Exchange, Inc.
February 2, 2006.
On December 23, 2005, Eli Lilly and Company, an Indiana corporation
(``Issuer''), filed an application with the Securities and Exchange
Commission (``Commission''), pursuant to section 12(d) of the
Securities Exchange Act of 1934 (``Act'') \1\ and Rule 12d2-2(d)
thereunder,\2\ to withdraw its common stock, no par value
(``Security''), from listing and registration on the Pacific Exchange,
Inc. (``PCX'').
---------------------------------------------------------------------------
\1\ 15 U.S.C. 78l(d).
\2\ 17 CFR 240.12d2-2(d).
---------------------------------------------------------------------------
On June 24, 2005, the Board of Directors (``Board'') of the Issuer
adopted resolutions to withdraw the Security from listing and
registration on PCX. The Issuer stated that it determined to withdraw
the Security from PCX for the followings reasons: (i) The Issuer
maintains its primary listing on the New York Stock Exchange, Inc.
(``NYSE'') as well as its secondary listings on the London Stock
Exchange and the SWX Swiss Stock Exchange; (ii) the Security is widely
traded on several electronic exchanges; (iii) in light of the strong
liquidity and visibility of the trading market for the Security on NYSE
and other exchanges, the additional expenses and administrative burden
of maintaining a secondary listing on PCX outweigh the benefits of
maintaining the listing on PCX.
The Issuer stated in its application that it has complied with
applicable rules of PCX by providing PCX with the required documents
governing the withdrawal of securities from listing and registration on
PCX. The Issuer's application relates solely to the withdrawal of the
Security from listing on PCX, and shall not affect its continued
listing on NYSE or its obligation to be registered under section 12(b)
of the Act.\3\
---------------------------------------------------------------------------
\3\ 15 U.S.C. 78l(b).
---------------------------------------------------------------------------
Any interested person may, on or before February 28, 2006, comment
on the facts bearing upon whether the application has been made in
accordance with the rules of PCX, and what terms, if any, should be
imposed by the Commission for the protection of investors. All comment
letters may be submitted by either of the following methods:
Electronic Comments
Use the Commission's Internet comment form (https://
www.sec.gov/rules/delist.shtml); or
Send an e-mail to rule-comments@sec.gov. Please include
the File Number 1-06351 or;
Paper Comments
Send paper comments in triplicate to Nancy M. Morris,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.
All submissions should refer to File Number 1-06351. This file
number should be included on the subject line if e-mail is used. To
help us process and review your comments more efficiently, please use
only one method. The Commission will post all comments on the
Commission's Internet Web site (https://www.sec.gov/rules/delist.shtml).
Comments are also available for public inspection and copying in the
Commission's Public Reference Room. All comments received will be
posted without change; we do not edit personal identifying information
from submissions. You should submit only information that you wish to
make available publicly.
The Commission, based on the information submitted to it, will
issue an order granting the application after the date mentioned above,
unless the Commission determines to order a hearing on the matter.
For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.\4\
---------------------------------------------------------------------------
\4\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------
Nancy M. Morris,
Secretary.
[FR Doc. E6-1844 Filed 2-9-06; 8:45 am]
BILLING CODE 8010-01-P